Mitchell W. Krucoff

Duke University — United States

Medicine · Health Sciences

78h-index39.1kcitations514works4.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Coronary Interventions and Diagnostics(203), Acute Myocardial Infarction Research(178), Cardiac Imaging and Diagnostics(143), Antiplatelet Therapy and Cardiovascular Diseases(116), Cardiac electrophysiology and arrhythmias(76)

Publications509 total

Calcium Modification After Orbital Atherectomy and Balloon Angioplasty in Severely Calcified Lesions: The ECLIPSE OCT Substudy
Circulation Cardiovascular Interventions·2025· 3 cited
Scientific Priorities Related to the Use of Double Sequential External Defibrillation in Patients With Refractory Cardiac Arrest: Report From a Multistakeholder Thinktank
Journal of the American Heart Association·2025· 1 citedOpen Access
Contemporary Practice Patterns of Vasoactive Use in Cardiogenic Shock in the American Heart Association Cardiogenic Shock Registry
Journal of the American Heart Association·2025· 2 citedOpen Access
TCT-545 Pressure-Volume Loop Evaluation Supporting the Hemodynamic Performance of the Percutaneous Synchronized Cardiac Assist (PSCA) System
Journal of the American College of Cardiology·2025
TCT-996 One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI
Journal of the American College of Cardiology·2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention
Journal of the American College of Cardiology·2025· 12 cited
TCT-1015 External Validation of the xDAPT Machine Learning Model for Ischemic and Bleeding Risk After Percutaneous Coronary Intervention
Journal of the American College of Cardiology·2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium
EuroIntervention·2025· 6 citedOpen Access
Underrepresented patient populations in cardiovascular device trials: A transatlantic expert narrative on sex, age, demographic groups, and geographical background
International Journal of Cardiology·2025Open Access
Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study
International Journal of Cardiology·2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
EuroIntervention·2025· 2 cited
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium
European Heart Journal·2025· 35 citedOpen Access
Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study
Circulation Cardiovascular Interventions·2025
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial
The Lancet·2025· 37 cited
A Framework for Exception From Informed Consent in Trials Enrolling Patients With ST‐Segment–Elevation Myocardial Infarction and Cardiogenic Shock
Journal of the American Heart Association·2025· 4 citedOpen Access
Priorities for medical device regulatory approval: a report from the European Society of Cardiology Cardiovascular Round Table
European Heart Journal·2025· 3 citedOpen Access
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI
JACC: Cardiovascular Interventions·2025· 7 cited
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trial
American Heart Journal·2025Open Access
Underrepresented Patient Populations in Cardiovascular Device Trials: Transatlantic Consensus Recommendations on Sex, Age, Demographic Groups, and Geographical Background
SSRN Electronic Journal·2025Open Access
Abstract 4144852: Contemporary Practice Patterns of Vasoactive Agents in Cardiogenic Shock: An Analysis of the AHA Cardiogenic Shock Registry
Circulation·2024
page 1 of 26Next →

Frequent Co-authors

Roxana Mehran(21), Donald E. Cutlip(19), Pascal Vranckx(12), Stephan Windecker(11), David J. Cohen(10), Patrick W. Serruys(10), A. Pieter Kappetein(10), Gerrit‐Anne van Es(8), Philippe Gabríel Steg(8), Sunil V. Rao(8), Michael J. Mack(8), C. Michael Gibson(8), Gregg W. Stone(8), Eugene H. Blackstone(7), Martin B. Leon(7), Andrew Farb(7), Nicolò Piazza(6), John G. Webb(6), Usman Baber(6), Dominick J. Angiolillo(6)